⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31644910 | 1.00 | — | — | |
| SCHEMBL6892814 | 0.95 | ACE (0.48) | — | |
| SCHEMBL22763367 | 0.92 | ACE (0.47) | — | |
| SCHEMBL22763115 | 0.92 | ACE (0.47) | — | |
| SCHEMBL15177758 | 0.92 | ACE (0.47) | — | |
| SCHEMBL20929057 | 0.83 | ACE (0.44) | — | |
| SCHEMBL13523741 | 0.80 | PEPD (0.61) | — | |
| SCHEMBL152714 | 0.80 | PEPD (0.61) | — | |
| SCHEMBL152716 | 0.80 | PEPD (0.61) | — | |
| SCHEMBL419838 | 0.80 | PEPD (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116200748-A | Ultra-high copper ion loaded metal etching solution composition and preparation method thereof | 四川和晟达电子科技有限公司 | 2023-06-02 | — | — | CN | claimed |
| WO-2025132542-A1 | MACROCYCLIC OREXIN AGONISTS | IDORSIA PHARMACEUTICALS LTD (CH) | 2025-06-26 | — | — | WO | disclosed |
| CN-116200748-B | Ultra-high copper ion loaded metal etching solution composition and preparation method thereof | 四川和晟达电子科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-116200748-A | Ultra-high copper ion loaded metal etching solution composition and preparation method thereof | 四川和晟达电子科技有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-20230139321-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | RAPT THERAPEUTICS, INC. | 2023-05-04 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-11384064-B2 | Chemokine receptor modulators and uses thereof | RAPT THERAPEUTICS, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20200325117-A1 | CHEMOKINE RECEPTOR MODULATORS AND USES THEREOF | FLX BIO, INC. | 2020-10-15 | — | — | US | disclosed |
| US-8309341-B2 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | Les Laboratories Server (FR) | 2012-11-13 | — | — | US | disclosed |
| US-8309341-B2 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | Les Laboratories Server (FR) | 2012-11-13 | — | — | US | disclosed |
| EP-2272826-A1 | 2-mercaptopentancarboxylic acid derivatives, the method for preparing them and the pharmaceutical compositions containing them | Les Laboratoires Servier (FR) | 2011-01-12 | — | — | EP | disclosed |
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-12-30 | — | — | US | disclosed |
| US-20100330064-A1 | 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them | LES LABORATOIRES SERVIER (FR) | 2010-12-30 | — | — | US | disclosed |